Gong Z. Zhang
28 Fuxing Road
Haidian, 100853, China
Haidian, 100853, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Multiparametric magnetic resonance imaging of deep learning-based super-resolution reconstruction for predicting histopathologic grade in hepatocellular carcinoma.
Journal: World journal of gastroenterology
Published: July 04, 2025
Elucidating the dynamic tumor microenvironment through deep transcriptomic analysis and therapeutic implication of MRE11 expression patterns in hepatocellular carcinoma.
Journal: Cancer cell international
Published: December 03, 2024
An easily machine learning-based tool for preliminary risk assessment of microvascular invasion in hepatocellular carcinoma.
Journal: Surgical endoscopy
Published: October 31, 2024
Genetically-predicted effects of lifestyle factors on frailty: Evidence from Mendelian randomization study.
Journal: Archives of gerontology and geriatrics
Published: August 09, 2024
Perioperative impact of liver cirrhosis on robotic liver resection for hepatocellular carcinoma: a retrospective cohort study.
Journal: Surgical endoscopy
Published: April 15, 2024
DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer.
Journal: BMC cancer
Published: August 29, 2023
Multilevel effective surgical workflow recognition in robotic left lateral sectionectomy with deep learning: experimental research.
Journal: International journal of surgery (London, England)
Published: April 17, 2023
Automated diagnosis of pancreatic mucinous and serous cystic neoplasms with modality-fusion deep neural network using multi-modality MRIs.
Journal: Frontiers in oncology
Published: March 29, 2023
18F-FDG-PET/CT-based deep learning model for fully automated prediction of pathological grading for pancreatic ductal adenocarcinoma before surgery.
Journal: EJNMMI research
Published: February 14, 2023
Case Report: Persistent response to combination therapy of pemigatinib, chemotherapy, and immune checkpoint inhibitor in a patient with advanced intrahepatic cholangiocarcinoma.
Journal: Frontiers in immunology
Published: December 15, 2022
Last Updated: 09/26/2026